Centre for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals (CERAD)
2018.05.22 - Marek Pawłowski During the three-day NOMATEN Scientific Workshop (Świerk, 15-17.05.2018), a parallel session was organized for young radiopharmaceutical researchers as well a plenary session on radiopharmaceuticals, which ended with a round table discussion. Over 10 presentations were delivered, including three plenary talks.
2018.05.14 - udgov_hs Work is ongoing on the construction site of Centre for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals “CERAD” in Świerk. In the site, where the three-story building and a laboratory will be situated, an old boiler room has been already demolished and its fundations are being removed.
2017.12.14 - Marek Pawłowski The Cracow-based CP OK2 Sp. z o.o. company has won EU tender proceedings to build in Świerk a centre for design and synthesis of new molecularly targeted drugs (CERAD). The company has signed the contract to build the facility before July 2021. Facility equipment will include a modern proton/deuteron/alpha particle cyclotron dedicated to produce radioisotopes.